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Summary 
Background and aims: Septic complications represent the pre-
dominant cause of late death in poly-trauma patients. The necessi-
ty to differentiate septic from non septic patients is more relevant
at the early stage of the illness in order to improve the clinical out-
come and to reduce the mortality. The identification of a sensitive
and specific, clinically reliable, biomarker capable to early recog-
nize incoming septic complications in trauma patients whose
expression is not influenced by concomitant traumatic injuries, is
still a challenge for the researchers in the field. 
Materials and methods: A retrospective analysis on 48 adult
patients (9 females and 39 males, mean age 47.6±19 years) with mul-
tiple trauma was performed. The inclusion criterion was to suffer
from acute trauma since no more than 24 hours and the exclusion cri-
teria were the following: antibiotic treatment on admission and main-
tained for more than 48 hours; on-going infection on admission not
associated with trauma; treatment with immunosuppressors/
immunomodulants; age <18 years old. Presepsin was measured
using an automated chemiluminescence analyser at 1, 3, 5 and 8 days
post of hospitalization. The diagnosis of systemic inflammatory
response syndrome (SIRS)/infection was established according to
the criteria of the Surviving Sepsis Campaign. 
Results and conclusions: In patients with SIRS, the mean pre-
sepsin concentration was 917,08 (±69.042) ng/L vs 980,258
(±1951.32) ng/L in patients without SIRS (P=0.769). In the infected
patients, the mean presepsin concentration was 1513.25 (±2296.54)
ng/L vs 654.21 (±511,068) ng/L (P<0.05) calculated among the non
infected upon admission. The plasma presepsin concentration
increased progressively during the first 8 days of hospitalization.
Presepsin concentration in the infected patients was significantly
higher than in non-infected patients. On the other hands no signifi-
cant differences were found in the plasma level of presepsin among
patients with and without SIRS. Any other clinical condition related
to the trauma did not affect presepsin. Our data clearly suggest that
presepsin may be considered an helpful diagnostic tool to early
diagnose sepsis in trauma patients.
Introduction
Trauma is the third leading cause of death in western countries
after cardiovascular disease and cancer, and it’s indeed the leading
cause for the population under the age of 45 years (24). Mortality
after traumatic events occurs in 45% of cases several days or weeks
after trauma as a result of complications that arise during hospital-
ization, like sepsis, respiratory distress syndrome (ARDS) and mul-
tiple organ failure (MOF) (7,8,18,22). Sepsis is mainly responsible
for death within the late complications of traumatic events. The early
identification of sepsis and the subsequent implementation of early
evidence-based therapies, including pathogen driven antibiotics,
have been documented to improve outcomes and to decrease the
sepsis-related mortality (8,9). Unfortunately the clinical picture of
trauma patients is often a specific due to the release of hormonal,
metabolic and immunological mediators (4,2,13,15,25); as a conse-
quence it is generally difficult to differentiate sepsis from non infec-
tion related SIRS (systemic inflammatory response syndrome).
Even the microbiological testing does not provide definitive diag-
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nostic information since culture based assays remain negative in up
to 50% of cases (8). As stated in the Surviving Sepsis Campaign
(SSC) guidelines, published in 2013, in the presence of septic shock,
each hour delay in achieving administration of effective antibiotics is
associated with a measurable increase in mortality (9,14). A useful
diagnostic help could come from sepsis biomarkers, which could
also guide the timing of antibiotic therapy and play a prognostic role
(19,21). The identification of a sensitive and specific biomarker able
to early recognize incoming septic complications in trauma patients
that at the same time is not influenced by concomitant traumatic
injuries, is still a challenge for researchers and the aim of this study
is fitting this research frame. A long series of potential biomarkers for
sepsis, many of which are of no clinical utility due to poor sensitivity
and specificity are described in the recent scientific literature (19,21).
Several studies demonstrated the clinical utility of one of these new
biomarkers: presepsin (sCD14-ST). Presepsin is reported to be valu-
able for the early diagnosis of sepsis, the patients risk stratification,
and the evaluation of prognosis in septic patients (11,16,23,26). This
soluble protein of 13kDa is produced by the plasma protease starting
from the soluble form of the membrane glycoprotein CD14 which is
expressed on the surface of monocytes, macrophages and granulo-
cytes. CD14 is a high affinity receptor for lipopolysaccharide (LPS)
and for the lipopolysaccharide binding protein (LBP). After the bind-
ing between LPS and CD14 through the LBP the transduction of a
series of signals is activated. This process lead to the release of
numerous cytokines that promote the inflammatory cascade. The sol-
uble form of CD14 of which presepsin is a sub-type (sCD14-ST) is
also liberated (6,16,21). According to several studies, plasma levels
of presepsin increased significantly in infected patients compared to
those with SIRS and non-infected ones. (11,12,14,16,17,23,26).
Presepsin levels increase in the early stages of sepsis before other
clinical signs of infection are present, and they further enhance dur-
ing its progression, reaching the greatest values in the stage of septic
shock (16). This data suggest that presepsin can be a good biomarker
to support clinicians in the management of septic patients. In this
study 48 poly-trauma patients were enrolled: based on this popula-
tion the evolution of presepsin plasma concentrations during the first
8 days of hospitalization in intensive care and its relationship with
infections has been studied. The principal aim was to establish if the
level of presepsin in plasma is or not influenced by traumatic injuries
or by the SIRS status: as a consequence the principal goal of the
study was to assess the potential usefulness of presepsin evaluation
for the early detection of incoming septic complications in patients
suffering from trauma. 
Materials and Methods
This retrospective study was performed on 48 patients suffer-
ing poly-trauma and admitted from July 2013 to October 2014 to
intensive care units in the Romagna area (northern Italy): 46 sub-
jects were hospitalized at the M. Bufalini hospital in Cesena, and 2
at the S.M. delle Croci hospital in Ravenna. All the patients
enrolled in the study were >18 years. Clinical data for each indi-
vidual patients were obtained from the consultation of individual
medical records. The inclusion criteria were the following: prophy-
laxis or antibiotic therapy started on admission and maintained for
more than 48 hours; on-going infections on admission (not associ-
ated with trauma); presence of penetrating injuries; presence of
skin lesion with important loss of substance or AISE (abbreviated
external injury scale) >3; immunosuppressive therapy and/or ther-
apy with steroids; immunosuppression status at the enrolment;
death within 8 days for non-infectious reasons. All the patients
older than 18 years that meet these criteria in the study period were
consecutively enrolled in the study. The following clinical and lab-
oratory data were collected for each individual patient in the study:
lactate and base excess (BE) on admission to the emergency room;
severity of traumatic injuries according to the ISS score (Injury
Severity Score) (BAKER); daily clinical severity [assessed using
the SOFA (Sequential Organ Failure Assessment) score, calculated
by using the worst daily values]; maximum daily temperature
(measured using a bladder thermistor); daily plasma concentration
of creatinin. Each patient was also evaluated daily for the presence
of SIRS and for the onset of infections. The plasma level of pre-
sepsin (presepsinemia) was evaluated at 24 hours after admission,
and on the 3rd, 5th and 8th day of hospitalization. The concentration
of presepsin was evaluated in left over samples originally used for
the counting of whole blood cells in EDTA containing (ethylene
diamine tetra acetic acid) tubes. Samples were collected and stored
according to the manufacturer instructions until used for the analy-
sis that was performed using the PATHFAST® system (Mitsubishi
Chemical Medience Corporation, Tokyo, Japan). This automated
instrument measures the plasma concentration of presespsin by
using magnetic particles coated with presepsin specific mouse
monoclonal antibodies and polyclonal antibodies obtained from
rabbits labelled with alkaline phosphatase (ALP labelled anti-
body). The presepsin in blood sample (whole blood or plasma)
binds to anti-presepsin antibodies and to ALP labelled antibody, to
form an immune complex. After removing unbound labelled ALP
antibodies using the MAGTRATION® technology (the magnetic
particles are washed directly into the tube), a chemiluminescent
substrate is added to the immune complex. After a short incubation
period (10 minutes), the luminescence generated by the enzymatic
reaction is detected by a photometer and, by measuring the emitted
light, the concentration of presepsin in the samples calculated. The
whole procedure is automatically performed using the PATHFAST
analyser in about 15 minutes and requires a total volume of 100 µL
sample. The SIRS status and the presence of infection have been
investigated retrospectively, based on data obtained from individ-
ual clinical record and considering the complete set of clinical
manifestations, the laboratory tests and imaging data, the results
obtained by standard of care microbiological testing (blood cul-
tures, tracheal aspirates, bronco lavages, urine cultures) according
to the International Sepsis Forum Consensus Conference on
Definitions of Infection criteria (10).
Statistical analysis
Data were reported as mean and standard deviation (SD) for
continuous variables, as median and interquartile range (IQR) for
ordinal variables and as percentage for the frequency distributions.
The distribution of data was evaluated preliminarily using the
Kolmogorov-Smirnov test. A comparison between means was per-
formed using the Student t-test for independent samples, for con-
tinuous variables with a normal distribution, and the Mann-
Whitney U test for continuous variables with non-normal distribu-
tions and non-continuous ordinal variables. The comparison
among the frequency distributions was made using the Chi-square
test and the correlation between variables was assessed with the
Spearman’s rank correlation test. 
Results
The demographic characteristics of the 48 patients enrolled are
summarised in in Table 1. Only one patient was found to be infect-
ed upon enrolment, with a clinical picture of septic shock resulting
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from intestinal ischemia, due to acute traumatic vascular injury and
intestinal micro perforation. This infection was clearly linked to
the traumatic event and consequently the patient was included in
the study. The infected patient, male, 65y-o, was hospitalized in
intensive care for 56 days, and was discharged alive. The following
data stated trauma severity in this patient: ISS 24, lactate 2 mmol/L
and BE 0.3 mmol/L on admission to the emergency room. In the
first 24 hours, the patient was transfused with 5 units of packed red
blood cells (1 unit = 280 mL) and 2 of fresh frozen plasma (1 bag
= 500 mL). The trauma severity data of the non-infected patients
on admission, were as follows; median ISS: 25 (IQR 20,25); aver-
age lactate values: 2.9±2 mmol/L and average BE values: −5.1±4.6
mmol/L. The first 24 hours, non-infected patients were transfused
with an average of 2.4±4.1 units of packed red blood cells, 0.4±0.8
units of platelets (1 unit = 250 mL) and 0.6±1.3 of fresh frozen
plasma bags. The trauma-related data are summarized in Table 2. 
Table 3 summarises the average values on the first day of admis-
sion in the ICU of presepsinaemia, lactate, creatinin and temperature
of uninfected patients, and their SOFA severity scores. The 47 unin-
fected patients’ presepsinaemia average value was 504.7±474.7 ng/L
on the first day of admission. The two highest values of presepsin in
uninfected patients (1585 ng/L and 1209 ng/L), have been observed
in patients with hepatic injury. Specifically, in a patient with active
HCV-related liver disease, and in a patient who was subjected to
hepatic packing. Correlation between presepsinaemia dosed on the
first day of hospitalization and the ISS score was analysed using the
Spearman Rho test and found to be −0.27 (Figure 1A); we also test-
ed the correlation between presepsinaemia on the first day and lac-
tate (Figure 1B) and BE dosed in the emergency room (0.211 and
−0.251 respectively). We found that there is no correlation between
these parameters and the value of presepsinaemia on the first day of
hospitalization. Among the 47 non-infected patients on admission,
15 (31.25%) showed a clinical SIRS during the first day in hospital.
The mean presepsinaemia at the first day in these uninfected patients
with SIRS was 657.6±739.4 ng/L, whilst the average value of pre-
sepsin in 32 (68.75%) uninfected patients without SIRS was
435.2±275.3 ng/L. There was no significant difference in the pre-
sepsinaemia measured in the first day of hospitalization between
non-infected patients with and without SIRS (P=0.275). Below, the
evolution of SIRS, of infection and presepsinaemia states in trauma
patients during the first 8 days of hospitalization in ICU is detailed.
Figure 2 shows the percentage of patients suffering from SIRS
and/or infections at the 1st, 3rd, 5th and 8th day of hospitalization.
The presepsinemia was measured at the same time intervals: the
average values of presepsin in the total 48 patients enrolled are
shown in Figure 3. In the only patient infected on admission, pre-
sepsinaemia on the 1st day was 2963 ng/L, that is six times higher
than the average value of presepsin found in uninfected patients.
The average values of presepsin calculated during the time interval
of the study for infected and uninfected patients are shown in
Figure 4. The highest absolute value of presepsinaemia was
observed in an infected patient on the 8th day (4063 ng/L). This
patient had liver lesions, and from the first day he showed higher
values of plasma presepsin concentration than other non-infected
patients. Among the patients with SIRS, the mean concentration of
presepsin was 917.086 (±69.042) ng/L while this value was
980,258 (±1951.32) ng/L in patients without SIRS (P=0.769)
(Figure 5A). The infected patients showed a mean concentration of
presepsin of 1513.25 (±2296.54) ng/L being 654.21 (±511,068)
ng/L in the non infected patients (P<0.05) (Figure 5B).
Discussion
The early diagnosis and clinical scoring of the severity of sepsis
increases the possibility to start a timely and specific therapy in order
to reduce mortality and improving the clinical outcomes of the
patients in the ICU. Because of the complex and nonspecific clinical
picture associated with trauma it is often quite difficult to make an
early diagnosis of the septic development and to differentiate sepsis
from SIRS. Several studies already demonstrated the utility of pre-
sepsin in the process of early identification of septic conditions in
different clinical ICU setting other than trauma affected patients
(17,28). In this study we want to study the role of presepsin in
patients entering the ICU immediately after an acute trauma
occurred, so that any other clinical condition that could influence the
level of presepsin concentration in plasma is basically excluded.
The variation of presepsinaemia during the first 8 days of hos-
pitalization in the ICU was evaluated and this parameter was cor-
related to the onset of infections: this correlation allowed us to
establish that there is an increasing trend of the values of presepsi-
naemia and these increased over time values are strictly linked to
the increase of the percentage of patients with an infection. The
sample population is indeed not large enough to draw an overall
robust conclusion, however, the evaluation of the presepsinaemia
values trend is likely a clinically valuable support in the manage-
ment of these trauma affected patients..
                                Article
Table 1. Demography of the studied population.
Characteristic                                                      
Mean age (SD)                                                       47.6 years (±19.0)
Gender
Male                                                                               39 (79.3%)
Female                                                                            9 (20.7%)
SD, standard deviation.
Table 2. Summary of the trauma-related parameters.
Trauma-related data                                          Missing patients
ISS, median (IQR)                               25 (20.25)                                1
ER lactate, mean (SD)                          2.9 (1,8)                                  7
ER base excess, mean (SD)              −5.1 (4.6)                                5
SD, standard deviation.
Table 3. Average values (standard deviation) detected on the first
day of admission in the Intensive Care Unit for presepsin plasma
concentration, lactate, creatinin. The last two lanes contains data
about temperature and SOFA severity scores for the uninfected
patients.
Parameters                                                 Mean (SD)
Presepsin                                                                      504.7 (474.7)
Lactate                                                                               2.1 (1.1)
Creatinin                                                                          0.98 (0.52)
Temperature max, C°                                                    37.9 (0.7)
SOFA, IQR                                                                            8 (4)
SD, standard deviation.
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Our results also demonstrated that there is no significant correla-
tion between the presepsinaemia values after 24 hour from traumatic
event and the severity of injuries expressed according to the ISS score
(P=−0.27). These data, suggest that presepsinaemia is not affected by
the extent of the traumatic injury in non-infected patients.
The clinical evaluation on admission of the 47 patients who
were uninfected allowed to differentiate two groups: 15 patients
had SIRS, whilst 33 did not have clinical SIRS evidence. A statis-
tical analysis showed that there was no significant difference
between presepsinaemia values in patients with SIRS and in those
without SIRS (P=0.275). Even when all the collected samples were
evaluated, no significant difference in the presepsinaemia was
observed between the group with SIRS and without SIRS
(P=0.769). These results suggest that presepsin may represent an
appropriate marker for the early detection of infections related to
trauma, since it is not affected by the SIRS status. The presepsi-
naemia values in infected patients showed a significant increase
when compared to the presepsin concentrations detected among
non-infected trauma patients (P<0.05) according to the evidence
already shown in the in literature (16,28). 
It was also of interest to analyse the data obtained for the only
one enrolled patient who was already infected, with a clinically
trauma related infection, upon admission: the value of presepsi-
naemia in the first day was 6 times greater than the average values
detected for the non-infected group (2963 ng/L). A very high
absolute value on admission could thus suggest the presence of
infection, even if it is of note that presepsin concentrations usually
increase with age and kidney dysfunction. As a consequence, the
interpretation of presepsin concentrations must also take into
account the age of the patients and their liver and kidney function
(6). All the patients included in this study did not show any renal
problems during the first 24 hours; however two patients had liver
lesions on admission and, although not infected, had presepsi-
naemia values respectively of 1585 ng/L and 1209 ng/L. The
mechanisms for producing and eliminating presepsin are not yet
fully known and it is thus possible to consider that in addition to
the renal system, the hepatic system could also be involved. 
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Figure 1. Correlation between presepsinaemia at the first day of
hospitalization and A) ISS score, B) lactate.
Figure 2. Percentage of patients suffering from SIRS and/or infections at the 1st, 3rd, 5th and 8th day of hospitalization.
No
n-c
om
me
rci
al 
us
e o
nly
Conclusions
In conclusion, blood presepsin levels significantly increased in
trauma patients who are infected, compared to the non-infected
ones; nor SIRS status, neither trauma injuries influenced presepsin
concentrations. These data allow to conclude that the detection of
presepsin plasma concentration over time on a regular schedule
from day 1 to 8 could play an important and potentially helpful role
in the in early diagnosis of sepsis in trauma patients. One important
limitation of this study is indeed the small number of patients
enrolled. Additional further studies on larger populations are need-
ed to better and deeper investigate the diagnostic role of presepsin
in trauma patients, and also to investigate its prognostic value and
its ability to predict therapeutic efficacy.
                                Article
Figure 3. Average values of presepsin plasma concentration in the
total 48 patients enrolled over the time (1st, 3rd, 5th and 8th day of
hospitalization).
Figure 4. Average values of presepsin plasma concentration calculated during the time interval of the study for infected and non-infected
patients.
Figure 5. Cumulative average values of presepsin calculated for the total time study for A) patients with and without SIRS; B) infected
and non-infected patients.
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